DATELINE : DAIRY
Dynamic Duo
FDA okays Aureomycin®-Bovatec® for dairy replacement heifers
A new FDA approval allowing the use of Aureomycin®
(chlortetracycline) and Bovatec® (lasalocid sodium) in the same
rations is expected to help dairy producers optimize feed efficiency
in replacement heifers while controlling coccidiosis and the
leading causes of bacterial pneumonia.
"For years, dairy producers have added Aureomycin and Bovatec to
their feed rations to maximize herd health and performance in dairy
replacement heifers. Now the two products can be fed together for
added convenience and flexibility," reports Dr. Lance Fox, a technical
service veterinarian for Alpharma Inc., Animal Health.
FAST FACTS
- Aureomycin-Bovatec helps optimize performance while controlling
coccidiosis and pneumonia.
- Complementary action helps keep
dairy cattle disease-free while
boosting efficiency and performance
- Feeding Aureomycin-Bovatec
makes producers less dependent on
labor-intensive injectable antibiotics
"Having the option of feeding a broad-spectrum antibiotic like
Aureomycin with Bovatec may present new disease-management
strategies for dairy herds," he adds.
Most of the trial work completed with the Aureomycin-Bovatec claim
involved beef cattle, but researchers at Kansas State University think
the combination will bring added efficiency and profitability to dairy
operations as well.
"I would think that the most immediate use for it would be in the
growing dairy replacement heifers, keeping them disease-free and
getting a boost in efficiency and performance," says Dr. Gerry Kuhl,
a retired cattle specialist from KSU who did some of the trial work
with the combination with colleague Dr. Frank Brazle.
"We know that ionophores like Bovatec are helpful in getting
animals to breed earlier, and so that’s always of interest to both
beef as well as dairy producers. I think the combination could make
a very economical and immediate impact on that segment of the
dairy industry."
Complementary Products
Dr. Twig Marston, a nutritionist and extension specialist at KSU, notes
that Aureomycin and Bovatec have different yet complementary modes
of action, which may account for the excellent performance seen when
the two medications are used in the same feed.
"The two products really complement each other very well," he says.
"Bovatec works on the rumen microflora to improve intestinal health
and allow animals to utilize the energy of feedstuffs more efficiently,"
he explains. "That, in turn, produces a healthier animal, one that can
respond better to antibiotic treatments."
‘Having the option of feeding a
broad-spectrum antibiotic like
Aureomycin with Bovatec
may
present new disease-management
strategies for dairy herds’
Kuhl thinks the new Aureomycin-Bovatec combination may make
producers less dependent on labor-intensive injectable antibiotics
and make it easier to protect herds from respiratory problems.
"In the past, if your animals were on Bovatec or another ionophore, you
had to use an injectable antibiotic for managing respiratory disease," he
says. "That was a real struggle because of the extra handling and labor
involved. The Aureomycin-Bovatec combination changes that scenario
dramatically, to the point where I think some consulting nutritionists will
now consider Bovatec because it can be fed with Aureomycin."
Adds Marston, "I think the combination has the potential to really
help considerably on a wide variety of forages. Certainly, it will be a
good tool during adverse weather, when respiratory problems are
more prevalent."
Flexible feeding
FDA has approved varying combinations of Aureomycin (50, 70, 90 and
100 grams per pound formulations) and Bovatec (20 grams per pound
liquid and 68 and 91 grams per pound formulations) for use in Type B
and Type C medicated cattle feeds.
Depending on dose rate, Aureomycin may be used for treating
bacterial pneumonia caused by Pasteurella multocida in calves, beef
and non-lactating dairy cattle.
Bovatec can be fed at various dose rates to improve feed efficiency
and rate of weight gain in cattle fed in confinement or on pasture for
slaughter (stocker, feeder cattle, dairy and beef replacement heifers).
In addition, Bovatec can be used to control coccidiosis caused by
Eimeria bovis and E. zuernii in cattle weighing up to 800 pounds.
®
©2006, Alpharma Inc. One Executive Drive Fort Lee, New Jersey 07024
1.800.645.4216 www.AlpharmaAH.com
For more information about the new Aureomycin-Bovatec combination, producers
should contact their feed supplier or Alpharma representative, or call
1.800.645.4216 or go to www.AlpharmaAH.com.
Aureomycin® and Bovatec® are registered trademarks of Alpharma Inc.